EUVIMEDEUVIMED entdecken
Open Access

Chemo-RaST with bortezomib inhibits multiple myeloma relapse

Anchal Ghai, Alexander Zheleznyak, Christopher Egbulefu, Nicole Blasi, Kvar Black, Rui Tang, Matthew L Cooper, Kiran Vij, Ravi Vij, John DiPersio, Monica Shokeen, Samuel Achilefu

Theranostics · 2025

DOI: 10.7150/thno.111508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Anchal Ghai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Bortezomib, Radioisotopes, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaBortezomibRadioisotopesAntineoplastic AgentsAnimalsMiceReactive Oxygen SpeciesHumansZirconiumCell Line, TumorAntibodies, MonoclonalNeoplasm Recurrence, LocalNanoparticlesDisease Models, AnimalFemaleMitochondriaRecurrenceTitanium

Stichwörter der Autor:innen

Radionuclide-stimulated dynamic therapy (RaST)bortezomibchemo-RaSTmyelomarelapsetherapy resistance

Substanzen

BortezomibReactive Oxygen SpeciesZirconiumdaratumumabAntibodies, MonoclonalRadioisotopesAntineoplastic AgentsZirconium-89Titanium

Autor:innen und Institutionen

  • Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Medicine, Washington University School of Medicine, Missouri, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, Missouri, USA.
  • Department of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.
  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Missouri, USA.

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • NIH HHS

Zitieren

APA

Ghai, A., Zheleznyak, A., Egbulefu, C., Blasi, N., Black, K., Tang, R., Cooper, M. L., Vij, K., Vij, R., DiPersio, J., Shokeen, M., & Achilefu, S. (2025). Chemo-RaST with bortezomib inhibits multiple myeloma relapse. Theranostics. https://doi.org/10.7150/thno.111508

Vancouver

Ghai A, Zheleznyak A, Egbulefu C, Blasi N, Black K, Tang R, et al. Chemo-RaST with bortezomib inhibits multiple myeloma relapse. Theranostics. 2025. doi:10.7150/thno.111508

BibTeX
@article{Ghai2025,
  author = {Ghai, Anchal and Zheleznyak, Alexander and Egbulefu, Christopher and Blasi, Nicole and Black, Kvar and Tang, Rui and Cooper, Matthew L and Vij, Kiran and Vij, Ravi and DiPersio, John and Shokeen, Monica and Achilefu, Samuel},
  title = {Chemo-RaST with bortezomib inhibits multiple myeloma relapse},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.111508}
}
Kostenlos starten →